{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:43Z","timestamp":1791928903174,"version":"4.3.4"},"reference-count":54,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"2","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"DOI":"10.1167\/iovs.66.2.24","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T10:31:26Z","timestamp":1738924286000},"page":"24","source":"Crossref","is-referenced-by-count":1,"title":["Transvitreal Retinochoroidal Biopsies of Primary Uveal Melanoma Reveal an Association of Low HLA Class I and High NK Cell Abundance in Low-Risk Disease"],"prefix":"10.1167","volume":"66","author":[{"given":"Kalijn Fredrike","family":"Bol","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands"},{"name":"Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands"},{"name":"National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Wilhelmus Dirk","family":"Sweep","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands"},{"name":"Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Douglas","family":"Crowther","sequence":"additional","affiliation":[{"name":"National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Antonius Johannes","family":"Gorris","sequence":"additional","affiliation":[{"name":"Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Aroca Lara","sequence":"additional","affiliation":[{"name":"Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands"},{"name":"Data Science, Institute for Computing and Information Sciences, Radboud University, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Draghi","sequence":"additional","affiliation":[{"name":"National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Marie","family":"Bagger","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Faber","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Textor","sequence":"additional","affiliation":[{"name":"Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands"},{"name":"Data Science, Institute for Computing and Information Sciences, Radboud University, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Donia","sequence":"additional","affiliation":[{"name":"National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Folke","family":"Kiilgaard","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge Marie","family":"Svane","sequence":"additional","affiliation":[{"name":"National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The national cancer data base report on cutaneous and noncutaneous melanoma","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000480640","article-title":"Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973\u20132013)","volume":"4","author":"Aronow","year":"2018","journal-title":"Ocul Oncol Pathol"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1136\/bjophthalmol-2021-319700","article-title":"Incidence and mortality of uveal melanoma in Australia (1982\u20132014)","volume":"107","author":"Beasley","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1167\/iovs.64.13.45","article-title":"Worldwide incidence of ocular melanoma and correlation with pigmentation-related risk factors","volume":"64","author":"Wu","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1056\/NEJMc1713444","article-title":"Tumor mutational burden and response rate to PD-1 inhibition","volume":"377","author":"Yarchoan","year":"2017","journal-title":"N Engl J Med"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.1167\/iovs.12-10427","article-title":"High throughput mass spectrometry-based mutation profiling of primary uveal melanoma","volume":"53","author":"Daniels","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.3390\/ijms21155231","article-title":"Genetic biomarkers in melanoma of the ocular region: what the medical oncologist should know","volume":"21","author":"Bol","year":"2020","journal-title":"Int J Mol Sci"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s41588-019-0440-9","article-title":"The genetic evolution of metastatic uveal melanoma","volume":"51","author":"Shain","year":"2019","journal-title":"Nat Genet"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1001\/jamaophthalmol.2016.0903","article-title":"Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes","volume":"134","author":"Decatur","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1200\/JCO.24.00447","article-title":"15-gene expression profile and PRAME as integrated prognostic test for uveal melanoma: first report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1)","volume":"42","author":"Harbour","year":"2024","journal-title":"J Clin Oncol"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/curroncol31010002","article-title":"Management of uveal melanoma: updated cancer care Alberta clinical practice guideline","volume":"31","author":"Weis","year":"2023","journal-title":"Curr Oncol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1001\/jamaophthalmol.2014.5395","article-title":"International validation of the American Joint Committee on Cancer's 7th edition classification of uveal melanoma","volume":"133","author":"AJCC Ophthalmic Oncology Task Force","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1001\/archopht.119.5.670","article-title":"Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15","volume":"119","author":"Collaborative Ocular Melanoma Study Group","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41571-022-00714-1","article-title":"Advances in the clinical management of uveal melanoma","volume":"20","author":"Carvajal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.1200\/JCO.23.01136","article-title":"Systemic therapy for melanoma: ASCO guideline update","volume":"41","author":"Seth","year":"2023","journal-title":"J Clin Oncol"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1056\/NEJMoa2304753","article-title":"Three-year overall survival with tebentafusp in metastatic uveal melanoma","volume":"389","author":"Hassel","year":"2023","journal-title":"N Engl J Med"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1200\/JCO.20.00605","article-title":"Nivolumab and ipilimumab in metastatic uveal melanoma: results from a single-arm phase II study","volume":"39","author":"Pelster","year":"2021","journal-title":"J Clin Oncol"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1200\/JCO.20.00550","article-title":"Nivolumab plus ipilimumab for treatment-naive metastatic uveal melanoma: an open-label, multicenter, phase II trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)","volume":"39","author":"Piulats","year":"2021","journal-title":"J Clin Oncol"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"7887","DOI":"10.1038\/s41598-024-55675-5","article-title":"Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis","volume":"14","author":"Yamada","year":"2024","journal-title":"Sci Rep"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/CMR.0000000000000900","article-title":"Efficacy of immune checkpoint inhibition in metastatic uveal melanoma: a systematic review and meta-analysis","volume":"33","author":"Pham","year":"2023","journal-title":"Melanoma Res"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3390\/cancers11101489","article-title":"Real-world impact of immune checkpoint inhibitors in metastatic uveal melanoma","volume":"11","author":"Bol","year":"2019","journal-title":"Cancers (Basel)"},{"key":"bib22","first-page":"2603","article-title":"Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma","volume":"34","author":"Whelchel","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/cncr.21283","article-title":"The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase","volume":"104","author":"Piras","year":"2005","journal-title":"Cancer"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3389\/fimmu.2020.01218","article-title":"Pan-cancer analysis of immune cell infiltration identifies a prognostic immune-cell characteristic score (ICCS) in lung adenocarcinoma","volume":"11","author":"Zuo","year":"2020","journal-title":"Front Immunol"},{"key":"bib25","first-page":"1414","article-title":"Tumor-infiltrating macrophages (CD68+ cells) and prognosis in malignant uveal melanoma","volume":"42","author":"M\u00e4kitie","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12864-022-08586-6","article-title":"Association between high immune activity and worse prognosis in uveal melanoma and low-grade glioma in TCGA transcriptomic data","volume":"23","author":"Matsuo","year":"2022","journal-title":"BMC Genomics"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1167\/iovs.11-9280","article-title":"Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma","volume":"53","author":"Bronkhorst","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1038\/s12276-023-01115-9","article-title":"Single-cell characterization of macrophages in uveal melanoma uncovers transcriptionally heterogeneous subsets conferring poor prognosis and aggressive behavior","volume":"55","author":"Li","year":"2023","journal-title":"Exp Mol Med"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1167\/iovs.07-0786","article-title":"Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma","volume":"49","author":"Maat","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1167\/iovs.10-5979","article-title":"Detection of M2-macrophages in uveal melanoma and relation with survival","volume":"52","author":"Bronkhorst","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"e947169","DOI":"10.4161\/21624011.2014.947169","article-title":"Molecular profiling of primary uveal melanomas with tumor-infiltrating lymphocytes","volume":"8","author":"Triozzi","year":"2019","journal-title":"Oncoimmunology"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"1758834018757175","DOI":"10.1177\/1758834018757175","article-title":"Treatment of uveal melanoma: where are we now?","volume":"10","author":"Yang","year":"2018","journal-title":"Ther Adv Med Oncol"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/bjophthalmol-2013-304006","article-title":"Brachytherapy and endoresection for choroidal melanoma: a cohort study","volume":"98","author":"Rice","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.ophtha.2013.07.043","article-title":"The ocular consequences and applicability of minimally invasive 25-gauge transvitreal retinochoroidal biopsy","volume":"120","author":"Bagger","year":"2013","journal-title":"Ophthalmology"},{"key":"bib35","first-page":"e65717","article-title":"Multiplex immunohistochemical analysis of the spatial immune cell landscape of the tumor microenvironment","volume":"198","author":"Gorris","year":"2023","journal-title":"J Vis Exp"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"bpae094","DOI":"10.1093\/biomethods\/bpae094","article-title":"ImmuNet: a segmentation-free machine learning pipeline for immune landscape phenotyping in tumors by multiplex imaging","volume":"10","author":"Sultan","year":"2024","journal-title":"Biol Methods Protoc"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1167\/iovs.08-2733","article-title":"Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients","volume":"50","author":"Maat","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"446","DOI":"10.4049\/jimmunol.2300263","article-title":"Balanced epigenetic regulation of MHC class I expression in tumor cells by the histone ubiquitin modifiers BAP1 and PCGF1","volume":"212","author":"Wijdeven","year":"2024","journal-title":"J Immunol"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"e000960","DOI":"10.1136\/jitc-2020-000960","article-title":"Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy","volume":"8","author":"Qin","year":"2020","journal-title":"J Immunother Cancer"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"7397","DOI":"10.1073\/pnas.1315398111","article-title":"Basal NF-?B controls IL-7 responsiveness of quiescent naive T cells","volume":"111","author":"Miller","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"e20232094","DOI":"10.1084\/jem.20232094","article-title":"Divergent local and systemic antitumor response in primary uveal melanomas","volume":"221","author":"Lucibello","year":"2024","journal-title":"J Exp Med"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1126\/science.abb9847","article-title":"Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer","volume":"370","author":"Krishna","year":"2020","journal-title":"Science"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.pathol.2023.08.003","article-title":"Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort","volume":"55","author":"Lamas","year":"2023","journal-title":"Pathology"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41467-019-14256-1","article-title":"Single-cell analysis reveals new evolutionary complexity in uveal melanoma","volume":"11","author":"Durante","year":"2020","journal-title":"Nat Commun"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41416-023-02331-w","article-title":"Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases","volume":"129","author":"Mariani","year":"2023","journal-title":"Br J Cancer"},{"key":"bib47","first-page":"3198","article-title":"Studies of tumor-infiltrating lymphocytes from a human choroidal melanoma","volume":"32","author":"Ksander","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/cancers11081102","article-title":"Loss of BAP1 is associated with upregulation of the NF?B pathway and increased HLA class I expression in uveal melanoma","volume":"11","author":"Souri","year":"2019","journal-title":"Cancers (Basel)"},{"key":"bib49","first-page":"1865","article-title":"Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma","volume":"38","author":"Blom","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib50","first-page":"2153","article-title":"Association of HLA class I and class II antigen expression and mortality in uveal melanoma","volume":"42","author":"Ericsson","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13046-023-02917-5","article-title":"Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease","volume":"43","author":"Neo","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/BF00186516","article-title":"HLA expression and tumor-infiltrating immune cells in uveal melanoma","volume":"234","author":"de Waard-Siebinga","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000267140","article-title":"Infiltrating lymphocytes and antigen expression in uveal melanoma","volume":"24","author":"Meecham","year":"1992","journal-title":"Ophthalmic Res"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3390\/cancers11081132","article-title":"HLA expression in uveal melanoma: an indicator of malignancy and a modifiable immunological target","volume":"11","author":"Souri","year":"2019","journal-title":"Cancers (Basel)"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.66.2.24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:00Z","timestamp":1791927120000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.66.2.24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,3]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.2.24","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,7]]}}}